Email Address / User Name:
Password:
:Remember Login
 


REGISTER HERE

Why Register?
SqueezeTrigger Info
Naked Short Exposed
Naked Short Update
Naked Short Proof
Phantom Shares
TV commercial
Cramer on Shorts
No Short List
New Short Rules
New Reg SHO
SEC Enforces SHO
New UpTick Rule
Services
  SqueezeTrigger Data
Naked Short Data
SqueezeTrigger    Alerts!
SqueezeTrigger    Reports
SqueezeTrigger    Portfolio
Naked Short List
  New to List
Buyin Imminent
Off List Today

Trade Signals
Performance
  by date
  2013-06-14
2013-06-13
2013-06-12
2013-06-11
2013-06-10
2013-06-07
2013-06-06
2013-06-05
2013-06-04
2013-06-03
2013-05-31
2013-05-30
2013-05-29
2013-05-28
2013-05-24
2013-05-23
2013-05-22
2013-05-21
2013-05-20
2013-05-17
  by exchange
  NASDAQ
AMEX
NYSE
Press Releases
  Naked Short News
SqueezeTrigger News
Friction Factor News
All Releases
Articles
  Bloomberg Article
NY Post Article
New Buyin Rule
Naked Short Article
Naked Short Survey
Naked Shorts Beware
RegSHO Amendment
RegSHO Updated
RegSHO Legal Study
  Contact Us
About Us

Symbol :

Listed 6 Consecutive Market Days. On List as of 01/25/2012 Through 02/02/2012

Current Quote*

Last: $1.290
Volume: 389,731

As Of: 2013-06-17 13:40:27 ET
*Quotes delayed by 20min.

BioSante Pharmaceuticals Inc (NASDAQ:BPAX)
Industry: Healthcare

BioSante Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development of various products for female sexual health and oncology. It provides LibiGel, a transdermal testosterone gel that is in Phase III clinical development for the treatment of female sexual dysfunction; and male testosterone gel for the treatment of hypogonadism in men, which is licensed to Teva Pharmaceuticals USA, Inc. The company also offers various cancer vaccines, which are in Phase I and Phase II clinical trials for the treatment of melanoma, leukemia, pancreatic, breast, and prostate cancer; The Pill-Plus, which is in Phase II clinical trials is a combination of estrogens, progestogens, and androgens to prevent testosterone deficiency; and Elestrin, a food and drug administration approved product for the treatment of hot flashes associated with menopause. BioSante Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Lincolnshire, Illinois.


Realtime Data


BuyIns.Net Releases for Symbol BPAX



3 Month

6 Month

1 Year